{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:12:17Z","timestamp":1794035537926,"version":"4.8.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:sec><jats:title>Abstract<\/jats:title><jats:p>Sepsis and septic shock remain drivers for morbidity and mortality in critical illness. The clinical picture of patients presenting with these syndromes evolves rapidly and may be characterised by: (a) microbial host invasion, (b) establishment of an infection focus, (c) opsonisation of bacterial products (e.g. lipopolysaccharide), (d) recognition of pathogens resulting in an immune response, (e) cellular and humoral effects of circulating pathogen and pathogen products, (f) immunodysregulation and endocrine effects of cytokines, (g) endothelial and organ damage, and (h) organ crosstalk and multiple organ dysfunction. Each step may be a potential target for a specific therapeutic approach. At various stages, extracorporeal therapies may target circulating molecules for removal. In sequence, we could consider: (a) pathogen removal from the circulation with affinity binders and cartridges (specific), (b) circulating endotoxin removal by haemoperfusion with polymyxin B adsorbers (specific), (c) cytokine removal by haemoperfusion with sorbent cartridges or adsorbing membranes (non-specific), (d) extracorporeal organ support with different techniques for respiratory and cardiac support (CO<jats:sub>2<\/jats:sub>removal or extracorporeal membrane oxygenation), and renal support (haemofiltration, haemodialysis, or ultrafiltration). The sequence of events and the use of different techniques at different points for specific targets will likely require trials with endpoints other than mortality. Instead, the primary objectives should be to achieve the desired action by using extracorporeal therapy at a specific point.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphical Abstract<\/jats:title><\/jats:sec>","DOI":"10.1186\/s13054-023-04310-2","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:04:06Z","timestamp":1675782246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Rationale for sequential extracorporeal therapy (SET) in sepsis"],"prefix":"10.1186","volume":"27","author":[{"given":"Claudio","family":"Ronco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakhmir","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeq","family":"Husain-Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"issue":"11","key":"4310_CR1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181\u2013247.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4310_CR2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4310_CR3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/CCM.0000000000002206","volume":"45","author":"JA Kellum","year":"2017","unstructured":"Kellum JA, Pike F, Yealy DM, Huang DT, Shapiro NI, Angus DC, Protocol-based Care for Early Septic Shock Investigators I. Relationship between alternative resuscitation strategies, host response and injury biomarkers, and outcome in septic shock: analysis of the protocol-based care for early septic shock study. Crit Care Med. 2017;45(3):438\u201345.","journal-title":"Crit Care Med"},{"issue":"10","key":"4310_CR4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nri2402","volume":"8","author":"D Rittirsch","year":"2008","unstructured":"Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8(10):776\u201387.","journal-title":"Nat Rev Immunol"},{"issue":"15","key":"4310_CR5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1001\/archinte.167.15.1655","volume":"167","author":"JA Kellum","year":"2007","unstructured":"Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167(15):1655\u201363.","journal-title":"Arch Intern Med"},{"issue":"1","key":"4310_CR6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13054-018-2181-z","volume":"22","author":"G Ankawi","year":"2018","unstructured":"Ankawi G, Neri M, Zhang J, Breglia A, Ricci Z, Ronco C. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls. Crit Care. 2018;22(1):262.","journal-title":"Crit Care"},{"issue":"8","key":"4310_CR7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"9","key":"4310_CR8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"4310_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40635-018-0177-2","volume":"6","author":"B Malard","year":"2018","unstructured":"Malard B, Lambert C, Kellum JA. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med Exp. 2018;6(1):12.","journal-title":"Intensive Care Med Exp"},{"issue":"12","key":"4310_CR10","doi-asserted-by":"crossref","first-page":"e422","DOI":"10.1016\/S1473-3099(19)30567-5","volume":"19","author":"I Rubio","year":"2019","unstructured":"Rubio I, Osuchowski MF, Shankar-Hari M, Skirecki T, Winkler MS, Lachmann G, La Rosee P, Monneret G, Venet F, Bauer M, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. 2019;19(12):e422\u201336.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"4310_CR11","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00134-018-5329-z","volume":"44","author":"F Husain-Syed","year":"2018","unstructured":"Husain-Syed F, Ricci Z, Brodie D, Vincent JL, Ranieri VM, Slutsky AS, Taccone FS, Gattinoni L, Ronco C. Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk. Intensive Care Med. 2018;44(9):1447\u201359.","journal-title":"Intensive Care Med"},{"issue":"21","key":"4310_CR12","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.3390\/ijms20215376","volume":"20","author":"M Huang","year":"2019","unstructured":"Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):5376.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4310_CR13","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/jcm10081742","volume":"10","author":"DB Darden","year":"2021","unstructured":"Darden DB, Kelly LS, Fenner BP, Moldawer LL, Mohr AM, Efron PA. Dysregulated immunity and immunotherapy after sepsis. J Clin Med. 2021;10(8):1742.","journal-title":"J Clin Med"},{"issue":"7","key":"4310_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41581-018-0005-7","volume":"14","author":"C Lelubre","year":"2018","unstructured":"Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 2018;14(7):417\u201327.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4310_CR15","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13054-019-2431-8","volume":"23","author":"RS Nannan Panday","year":"2019","unstructured":"Nannan Panday RS, Lammers EMJ, Alam N, Nanayakkara PWB. An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. Crit Care. 2019;23(1):182.","journal-title":"Crit Care"},{"issue":"1","key":"4310_CR16","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1038\/s41598-021-86346-4","volume":"11","author":"L Mellhammar","year":"2021","unstructured":"Mellhammar L, Kahn F, Whitlow C, Kander T, Christensson B, Linder A. Bacteremic sepsis leads to higher mortality when adjusting for confounders with propensity score matching. Sci Rep. 2021;11(1):6972.","journal-title":"Sci Rep"},{"issue":"2","key":"4310_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00134-009-1705-z","volume":"36","author":"F Bloos","year":"2010","unstructured":"Bloos F, Hinder F, Becker K, Sachse S, Mekontso Dessap A, Straube E, Cattoir V, Brun-Buisson C, Reinhart K, Peters G, et al. A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med. 2010;36(2):241\u20137.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4310_CR18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/23744235.2018.1562205","volume":"51","author":"I Ziegler","year":"2019","unstructured":"Ziegler I, Cajander S, Rasmussen G, Ennefors T, Molling P, Stralin K. High nuc DNA load in whole blood is associated with sepsis, mortality and immune dysregulation in Staphylococcus aureus bacteraemia. Infect Dis (Lond). 2019;51(3):216\u201326.","journal-title":"Infect Dis (Lond)"},{"issue":"3","key":"4310_CR19","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1378\/chest.09-0258","volume":"136","author":"J Rello","year":"2009","unstructured":"Rello J, Lisboa T, Lujan M, Gallego M, Kee C, Kay I, Lopez D, Waterer GW. Group DN-NS: severity of pneumococcal pneumonia associated with genomic bacterial load. Chest. 2009;136(3):832\u201340.","journal-title":"Chest"},{"key":"4310_CR20","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"4310_CR21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1159\/000504144","volume":"46","author":"G Stussi","year":"2019","unstructured":"Stussi G, Buser A, Holbro A. Red blood cells: exchange, transfuse, or deplete. Transfus Med Hemother. 2019;46(6):407\u201316.","journal-title":"Transfus Med Hemother"},{"key":"4310_CR22","doi-asserted-by":"publisher","unstructured":"Bartlett AH, Park PW. Heparan sulfate proteoglycans in infection. Glycans in diseases and therapeutics. 2011, p. 31\u201362. https:\/\/doi.org\/10.1007\/978-3-642-16833-8_2.","DOI":"10.1007\/978-3-642-16833-8_2"},{"issue":"21","key":"4310_CR23","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01357-21","volume":"95","author":"N Shiliaev","year":"2021","unstructured":"Shiliaev N, Lukash T, Palchevska O, Crossman DK, Green TJ, Crowley MR, Frolova EI, Frolov I. Natural and recombinant SARS-CoV-2 isolates rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1\/S2 cleavage. J Virol. 2021;95(21): e0135721.","journal-title":"J Virol"},{"issue":"1","key":"4310_CR24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000508647","volume":"50","author":"MT Seffer","year":"2021","unstructured":"Seffer MT, Cottam D, Forni LG, Kielstein JT. Heparin 2.0: a new approach to the infection crisis. Blood Purif. 2021;50(1):28\u201334.","journal-title":"Blood Purif"},{"issue":"6","key":"4310_CR25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4014\/jmb.1102.02016","volume":"21","author":"I Mattsby-Baltzer","year":"2011","unstructured":"Mattsby-Baltzer I, Bergstrom T, McCrea K, Ward R, Adolfsson L, Larm O. Affinity apheresis for treatment of bacteremia caused by Staphylococcus aureus and\/or methicillin-resistant S. aureus (MRSA). J Microbiol Biotechnol. 2011;21(6):659\u201364.","journal-title":"J Microbiol Biotechnol"},{"issue":"12","key":"4310_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114242","volume":"9","author":"K McCrea","year":"2014","unstructured":"McCrea K, Ward R, LaRosa SP. Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media. PLoS ONE. 2014;9(12): e114242.","journal-title":"PLoS ONE"},{"issue":"12","key":"4310_CR27","doi-asserted-by":"crossref","first-page":"A1597","DOI":"10.1097\/01.ccm.0000458481.24778.04","volume":"42","author":"S LaRosa","year":"2014","unstructured":"LaRosa S, McCrea K, Ward R. 984: removal of cytomegalovirus from blood by heparin-functional hemoperfusion media. Crit Care Med. 2014;42(12):A1597.","journal-title":"Crit Care Med"},{"issue":"1","key":"4310_CR28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13054-021-03597-3","volume":"25","author":"JT Kielstein","year":"2021","unstructured":"Kielstein JT, Borchina DN, Fuhner T, Hwang S, Mattoon D, Ball AJ. Hemofiltration with the Seraph((R)) 100 Microbind((R)) Affinity filter decreases SARS-CoV-2 nucleocapsid protein in critically ill COVID-19 patients. Crit Care. 2021;25(1):190.","journal-title":"Crit Care"},{"key":"4310_CR29","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1007\/s15010-019-01341-2","volume":"47","author":"B Koch","year":"2019","unstructured":"Koch B, McCrea K, Buettner S, et al. \u201c9th international congress \u201csepsis and multiorgan dysfunction\u201d: protecting the endothelium with hemoperfusion during sepsis (abstract). Infection. 2019;47:S1\u201367. https:\/\/doi.org\/10.1007\/s15010-019-01341-2.","journal-title":"Infection"},{"key":"4310_CR30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/03913988211038230","volume":"44","author":"M Ebeyer-Masotta","year":"2021","unstructured":"Ebeyer-Masotta M, Eichhorn T, Krajcik Laukov\u00e1 L, Weber V. ESAO 2021: adsorption of histones\/nucleosomes, high-mobility group BOX-1 protein and platelet factor 4 by heparin-immobilized matrices (abstract). Int J Artif Organs. 2021;44:628\u20139. https:\/\/doi.org\/10.1177\/03913988211038230.","journal-title":"Int J Artif Organs"},{"issue":"2","key":"4310_CR31","doi-asserted-by":"crossref","first-page":"L321","DOI":"10.1152\/ajplung.00337.2020","volume":"321","author":"L Chen","year":"2021","unstructured":"Chen L, Kraft BD, Roggli VL, Healy ZR, Woods CW, Tsalik EL, Ginsburg GS, Murdoch DM, Suliman HB, Piantadosi CA, et al. Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia. Am J Physiol Lung Cell Mol Physiol. 2021;321(2):L321\u201335.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"4310_CR32","doi-asserted-by":"crossref","first-page":"e235262","DOI":"10.1136\/bcr-2020-235262","volume":"13","author":"MT Seffer","year":"2020","unstructured":"Seffer MT, Eden G, Engelmann S, Kielstein JT. Elimination of Staphylococcus aureus from the bloodstream using a novel biomimetic sorbent haemoperfusion device. BMJ Case Rep. 2020;13(8):e235262.","journal-title":"BMJ Case Rep"},{"issue":"3","key":"4310_CR33","first-page":"421","volume":"13","author":"JJ Schmidt","year":"2020","unstructured":"Schmidt JJ, Eden G, Seffer MT, Winkler M, Kielstein JT. In vitro elimination of anti-infective drugs by the Seraph((R)) 100 Microbind((R)) affinity blood filter. Clin Kidney J. 2020;13(3):421\u20134.","journal-title":"Clin Kidney J"},{"issue":"8","key":"4310_CR34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2215\/CJN.17601120","volume":"16","author":"JJ Schmidt","year":"2021","unstructured":"Schmidt JJ, Bode-Boger SM, Martens-Lobenhoffer J, Hoeper MM, Kielstein JT. Pharmacokinetics of remdesivir and GS-441524 during PIRRT and seraph 100 therapy. Clin J Am Soc Nephrol CJASN. 2021;16(8):1256\u20137.","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"6","key":"4310_CR35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1159\/000514523","volume":"50","author":"HRH de Geus","year":"2021","unstructured":"de Geus HRH, Smeets T, Hoek RAS, Endeman H, Hunfeld N. The Seraph(R)-100 microbind affinity blood filter does not affect vancomycin, tacrolimus, and mycophenolic acid plasma concentrations. Blood Purif. 2021;50(6):971\u20135.","journal-title":"Blood Purif"},{"issue":"1","key":"4310_CR36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1186\/s13054-020-03398-0","volume":"24","author":"JF Bermejo-Martin","year":"2020","unstructured":"Bermejo-Martin JF, Gonzalez-Rivera M, Almansa R, Micheloud D, Tedim AP, Dominguez-Gil M, Resino S, Martin-Fernandez M, Ryan Murua P, Perez-Garcia F, et al. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19. Crit Care. 2020;24(1):691.","journal-title":"Crit Care"},{"issue":"9","key":"4310_CR37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/cid\/ciab686","volume":"74","author":"JL Jacobs","year":"2022","unstructured":"Jacobs JL, Bain W, Naqvi A, Staines B, Castanha PMS, Yang H, Boltz VF, Barratt-Boyes S, Marques ETA, Mitchell SL, et al. severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes. Clin Infect Dis. 2022;74(9):1525\u201333.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4310_CR38","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1002\/jmv.26876","volume":"93","author":"K Tang","year":"2021","unstructured":"Tang K, Wu L, Luo Y, Gong B. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019. J Med Virol. 2021;93(5):3165\u201375.","journal-title":"J Med Virol"},{"issue":"2","key":"4310_CR39","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/cid\/ciab394","volume":"74","author":"N Ram-Mohan","year":"2022","unstructured":"Ram-Mohan N, Kim D, Zudock EJ, Hashemi MM, Tjandra KC, Rogers AJ, Blish CA, Nadeau KC, Newberry JA, Quinn JV, et al. SARS-CoV-2 RNAemia predicts clinical deterioration and extrapulmonary complications from COVID-19. Clin Infect Dis. 2022;74(2):218\u201326.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"4310_CR40","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000662","volume":"4","author":"SA Chitty","year":"2022","unstructured":"Chitty SA, Mobbs S, Rifkin BS, Stogner SW, Lewis MS, Betancourt J, DellaVolpe J, Abouzahr F, Wilhelm AM, Szerlip HM, et al. A multicenter evaluation of the seraph 100 microbind affinity blood filter for the treatment of severe COVID-19. Crit Care Explor. 2022;4(4): e0662.","journal-title":"Crit Care Explor"},{"issue":"4","key":"4310_CR41","first-page":"673","volume":"37","author":"JJ Schmidt","year":"2022","unstructured":"Schmidt JJ, Borchina DN, Van\u2019t Klooster M, Bulhan-Soki K, Okioma R, Herbst L, Rodriguez DS, Premuzic V, Buttner S, Bader B, et al. Interim analysis of the COSA (COVID-19 patients treated with the Seraph(R) 100 Microbind(R) Affinity filter) registry. Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc. 2022;37(4):673\u201380.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transplant Assoc Eur Renal Assoc"},{"issue":"2","key":"4310_CR42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/evan.21887","volume":"30","author":"JF Brinkworth","year":"2021","unstructured":"Brinkworth JF, Valizadegan N. Sepsis and the evolution of human increased sensitivity to lipopolysaccharide. Evol Anthropol. 2021;30(2):141\u201357.","journal-title":"Evol Anthropol"},{"issue":"3","key":"4310_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1556\/1886.2018.00017","volume":"8","author":"TM Wassenaar","year":"2018","unstructured":"Wassenaar TM, Zimmermann K. Lipopolysaccharides in food, food supplements, and probiotics: should we be worried? Eur J Microbiol Immunol (Bp). 2018;8(3):63\u20139.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"7","key":"4310_CR44","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s00134-002-1330-6","volume":"28","author":"PM Lepper","year":"2002","unstructured":"Lepper PM, Held TK, Schneider EM, Bolke E, Gerlach H, Trautmann M. Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med. 2002;28(7):824\u201333.","journal-title":"Intensive Care Med"},{"issue":"8","key":"4310_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1\u20139.","journal-title":"Exp Mol Med"},{"issue":"5","key":"4310_CR46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/01.shk.0000228797.41044.08","volume":"26","author":"KP Mollen","year":"2006","unstructured":"Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock. 2006;26(5):430\u20137.","journal-title":"Shock"},{"issue":"1\u20133","key":"4310_CR47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0165-022X(01)00228-7","volume":"49","author":"FB Anspach","year":"2001","unstructured":"Anspach FB. Endotoxin removal by affinity sorbents. J Biochem Biophys Methods. 2001;49(1\u20133):665\u201381.","journal-title":"J Biochem Biophys Methods"},{"issue":"2","key":"4310_CR48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ags3.12015","volume":"1","author":"T Shimizu","year":"2017","unstructured":"Shimizu T, Miyake T, Tani M. History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock. Ann Gastroenterol Surg. 2017;1(2):105\u201313.","journal-title":"Ann Gastroenterol Surg"},{"issue":"4\u20135","key":"4310_CR49","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1159\/000513213","volume":"50","author":"K Fujimori","year":"2021","unstructured":"Fujimori K, Tarasawa K, Fushimi K. Effects of polymyxin b hemoperfusion on septic shock patients requiring noradrenaline: analysis of a nationwide administrative database in Japan. Blood Purif. 2021;50(4\u20135):560\u20135.","journal-title":"Blood Purif"},{"issue":"1","key":"4310_CR50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13613-021-00928-z","volume":"11","author":"K Fujimori","year":"2021","unstructured":"Fujimori K, Tarasawa K, Fushimi K. Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study. Ann Intensive Care. 2021;11(1):141.","journal-title":"Ann Intensive Care"},{"issue":"6","key":"4310_CR51","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"DM Payen","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41(6):975\u201384.","journal-title":"Intensive Care Med"},{"issue":"14","key":"4310_CR52","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, et al. Effect of targeted polymyxin b hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320(14):1455\u201363.","journal-title":"JAMA"},{"issue":"8","key":"4310_CR53","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/1753425913516885","volume":"20","author":"T Ikeda","year":"2014","unstructured":"Ikeda T, Ikeda K, Suda S, Ueno T. Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients. Innate Immun. 2014;20(8):881\u20137.","journal-title":"Innate Immun"},{"issue":"3","key":"4310_CR54","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/422254","volume":"190","author":"JC Marshall","year":"2004","unstructured":"Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis. 2004;190(3):527\u201334.","journal-title":"J Infect Dis"},{"issue":"3","key":"4310_CR55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000475982","volume":"44","author":"AD Romaschin","year":"2017","unstructured":"Romaschin AD, Obiezu-Forster CV, Shoji H, Klein DJ. Novel insights into the direct removal of endotoxin by polymyxin B hemoperfusion. Blood Purif. 2017;44(3):193\u20137.","journal-title":"Blood Purif"},{"issue":"12","key":"4310_CR56","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44(12):2205\u201312.","journal-title":"Intensive Care Med"},{"key":"4310_CR57","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fimmu.2015.00422","volume":"6","author":"E Venereau","year":"2015","unstructured":"Venereau E, Ceriotti C, Bianchi ME. DAMPs from cell death to new life. Front Immunol. 2015;6:422.","journal-title":"Front Immunol"},{"issue":"7285","key":"4310_CR58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104\u20137.","journal-title":"Nature"},{"key":"4310_CR59","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3389\/fimmu.2019.02536","volume":"10","author":"NL Denning","year":"2019","unstructured":"Denning NL, Aziz M, Gurien SD, Wang P. DAMPs and NETs in sepsis. Front Immunol. 2019;10:2536.","journal-title":"Front Immunol"},{"issue":"4","key":"4310_CR60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1369\/0022155417740880","volume":"66","author":"CW Frevert","year":"2018","unstructured":"Frevert CW, Felgenhauer J, Wygrecka M, Nastase MV, Schaefer L. Danger-associated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity. J Histochem Cytochem. 2018;66(4):213\u201327.","journal-title":"J Histochem Cytochem"},{"issue":"6894","key":"4310_CR61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191\u20135.","journal-title":"Nature"},{"issue":"6","key":"4310_CR62","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/1744666X.2014.909730","volume":"10","author":"B Lu","year":"2014","unstructured":"Lu B, Wang C, Wang M, Li W, Chen F, Tracey KJ, Wang H. Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review. Expert Rev Clin Immunol. 2014;10(6):713\u201327.","journal-title":"Expert Rev Clin Immunol"},{"issue":"7500","key":"4310_CR63","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nature13085","volume":"509","author":"M Idzko","year":"2014","unstructured":"Idzko M, Ferrari D, Eltzschig HK. Nucleotide signalling during inflammation. Nature. 2014;509(7500):310\u20137.","journal-title":"Nature"},{"issue":"7261","key":"4310_CR64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","volume":"461","author":"MR Elliott","year":"2009","unstructured":"Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461(7261):282\u20136.","journal-title":"Nature"},{"issue":"11","key":"4310_CR65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2009.07.011","volume":"30","author":"V Papayannopoulos","year":"2009","unstructured":"Papayannopoulos V, Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol. 2009;30(11):513\u201321.","journal-title":"Trends Immunol"},{"issue":"11","key":"4310_CR66","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","volume":"15","author":"J Xu","year":"2009","unstructured":"Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, Taylor FB, Esmon NL, Lupu F, Esmon CT. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318\u201321.","journal-title":"Nat Med"},{"issue":"5","key":"4310_CR67","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.52","volume":"8","author":"E Silk","year":"2017","unstructured":"Silk E, Zhao H, Weng H, Ma D. The role of extracellular histone in organ injury. Cell Death Dis. 2017;8(5): e2812.","journal-title":"Cell Death Dis"},{"issue":"3","key":"4310_CR68","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3390\/ijms23031823","volume":"23","author":"M Ebeyer-Masotta","year":"2022","unstructured":"Ebeyer-Masotta M, Eichhorn T, Weiss R, Semak V, Laukova L, Fischer MB, Weber V. Heparin-functionalized adsorbents eliminate central effectors of immunothrombosis, including platelet factor 4, high-mobility group box 1 protein and histones. Int J Mol Sci. 2022;23(3):1823.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4310_CR69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233644","volume":"15","author":"J Hogwood","year":"2020","unstructured":"Hogwood J, Pitchford S, Mulloy B, Page C, Gray E. Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood. PLoS ONE. 2020;15(5): e0233644.","journal-title":"PLoS ONE"},{"key":"4310_CR70","first-page":"326","volume":"21","author":"L Wen-Sheng","year":"2022","unstructured":"Wen-Sheng L, Wei W, Min W. Effects of CVVH combined with HA330 hemoperfusion on serum HMGB1, hs-CRP and procalcitonin levels and 28-day mortality in post-traumatic sepsis patients with acute kidney injury. Chin J Blood Purif. 2022;21:326\u201330.","journal-title":"Chin J Blood Purif"},{"issue":"1","key":"4310_CR71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.179.1.269","volume":"179","author":"E Hailman","year":"1994","unstructured":"Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM, Wright SD. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med. 1994;179(1):269\u201377.","journal-title":"J Exp Med"},{"issue":"2","key":"4310_CR72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2567.2004.01976.x","volume":"113","author":"EM Palsson-McDermott","year":"2004","unstructured":"Palsson-McDermott EM, O\u2019Neill LA. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology. 2004;113(2):153\u201362.","journal-title":"Immunology"},{"issue":"2","key":"4310_CR73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138\u201350.","journal-title":"N Engl J Med"},{"issue":"1","key":"4310_CR74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","volume":"274","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA. The immune system\u2019s role in sepsis progression, resolution, and long-term outcome. Immunol Rev. 2016;274(1):330\u201353.","journal-title":"Immunol Rev"},{"issue":"3","key":"4310_CR75","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/CCM.0000000000000043","volume":"42","author":"GR Bernard","year":"2014","unstructured":"Bernard GR, Francois B, Mira JP, Vincent JL, Dellinger RP, Russell JA, Larosa SP, Laterre PF, Levy MM, Dankner W, et al. Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-alpha fragment antibody AZD9773 in adult patients with severe sepsis and\/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*. Crit Care Med. 2014;42(3):504\u201311.","journal-title":"Crit Care Med"},{"issue":"5","key":"4310_CR76","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1074-7613(00)80125-9","volume":"11","author":"R Callard","year":"1999","unstructured":"Callard R, George AJ, Stark J. Cytokines, chaos, and complexity. Immunity. 1999;11(5):507\u201313.","journal-title":"Immunity"},{"issue":"9","key":"4310_CR77","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1525-1594.2003.07289.x","volume":"27","author":"C Ronco","year":"2003","unstructured":"Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d\u2019Intini V, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27(9):792\u2013801.","journal-title":"Artif Organs"},{"key":"4310_CR78","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000313773","volume":"165","author":"Z Peng","year":"2010","unstructured":"Peng Z, Singbartl K, Simon P, Rimmele T, Bishop J, Clermont G, Kellum JA. Blood purification in sepsis: a new paradigm. Contrib Nephrol. 2010;165:322\u20138.","journal-title":"Contrib Nephrol"},{"issue":"Suppl 3","key":"4310_CR79","first-page":"1","volume":"47","author":"C Monard","year":"2019","unstructured":"Monard C, Rimmele T, Ronco C. Extracorporeal blood purification therapies for sepsis. Blood Purif. 2019;47(Suppl 3):1\u201314.","journal-title":"Blood Purif"},{"key":"4310_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13645706.2022.2104617","volume":"31","author":"A Nierhaus","year":"2022","unstructured":"Nierhaus A, Morales J, Wendt D, Scheier J, Gutzler D, Jarczak D, Born F, Hagl C, Deliargyris E, Mehta Y. Comparison of the CytoSorb((R)) 300 mL and Jafron HA380 hemoadsorption devices: an in vitro study. Minim Invasive Ther Allied Technol. 2022;31:1\u20138.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"4\u20135","key":"4310_CR81","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000510982","volume":"50","author":"TAC Snow","year":"2021","unstructured":"Snow TAC, Littlewood S, Corredor C, Singer M, Arulkumaran N. Effect of extracorporeal blood purification on mortality in sepsis: a meta-analysis and trial sequential analysis. Blood Purif. 2021;50(4\u20135):462\u201372.","journal-title":"Blood Purif"},{"issue":"5","key":"4310_CR82","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","volume":"96","author":"S Peerapornratana","year":"2019","unstructured":"Peerapornratana S, Manrique-Caballero CL, Gomez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083\u201399.","journal-title":"Kidney Int"},{"issue":"1","key":"4310_CR83","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13054-018-2077-y","volume":"22","author":"N Srisawat","year":"2018","unstructured":"Srisawat N, Tungsanga S, Lumlertgul N, Komaenthammasophon C, Peerapornratana S, Thamrongsat N, Tiranathanagul K, Praditpornsilpa K, Eiam-Ong S, Tungsanga K, et al. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients. Crit Care. 2018;22(1):279.","journal-title":"Crit Care"},{"issue":"10","key":"4310_CR84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187015","volume":"12","author":"D Schadler","year":"2017","unstructured":"Schadler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, Marx G, Putensen C, Spies C, Jorres A, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS ONE. 2017;12(10): e0187015.","journal-title":"PLoS ONE"},{"issue":"1","key":"4310_CR85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13613-021-00905-6","volume":"11","author":"C Scharf","year":"2021","unstructured":"Scharf C, Schroeder I, Paal M, Winkels M, Irlbeck M, Zoller M, Liebchen U. Can the cytokine adsorber CytoSorb((R)) help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis. Ann Intensive Care. 2021;11(1):115.","journal-title":"Ann Intensive Care"},{"issue":"13","key":"4310_CR86","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.121.056940","volume":"145","author":"M Diab","year":"2022","unstructured":"Diab M, Lehmann T, Bothe W, Akhyari P, Platzer S, Wendt D, Deppe AC, Strauch J, Hagel S, Gunther A, et al. Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): results from a multicenter randomized controlled trial. Circulation. 2022;145(13):959\u201368.","journal-title":"Circulation"},{"issue":"6","key":"4310_CR87","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/CCM.0000000000005493","volume":"50","author":"H Stockmann","year":"2022","unstructured":"Stockmann H, Thelen P, Stroben F, Pigorsch M, Keller T, Krannich A, Spies C, Treskatsch S, Ocken M, Kunz JV, et al. CytoSorb rescue for COVID-19 patients with vasoplegic shock and multiple organ failure: a prospective, open-label, randomized controlled pilot study. Crit Care Med. 2022;50(6):964\u201376.","journal-title":"Crit Care Med"},{"issue":"7","key":"4310_CR88","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-2600(21)00177-6","volume":"9","author":"A Supady","year":"2021","unstructured":"Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, Frech F, Muller S, Kuhl M, Benk C, et al. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021;9(7):755\u201362.","journal-title":"Lancet Respir Med"},{"issue":"8","key":"4310_CR89","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00063-017-0342-5","volume":"114","author":"S Friesecke","year":"2019","unstructured":"Friesecke S, Trager K, Schittek GA, Molnar Z, Bach F, Kogelmann K, Bogdanski R, Weyland A, Nierhaus A, Nestler F, et al. International registry on the use of the CytoSorb(R) adsorber in ICU patients: study protocol and preliminary results. Medizinische Klinik, Intensivmedizin und Notfallmedizin. 2019;114(8):699\u2013707.","journal-title":"Medizinische Klinik, Intensivmedizin und Notfallmedizin"},{"issue":"6","key":"4310_CR90","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1744-9987.2010.00825.x","volume":"14","author":"Z Huang","year":"2010","unstructured":"Huang Z, Wang SR, Su W, Liu JY. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2010;14(6):596\u2013602.","journal-title":"Ther Apher Dial"},{"issue":"4","key":"4310_CR91","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1744-9987.2012.01083.x","volume":"17","author":"Z Huang","year":"2013","unstructured":"Huang Z, Wang SR, Yang ZL, Liu JY. Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 2013;17(4):454\u201361.","journal-title":"Ther Apher Dial"},{"issue":"1\u20132","key":"4310_CR92","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000502680","volume":"49","author":"S Harm","year":"2020","unstructured":"Harm S, Schildbock C, Hartmann J. Cytokine removal in extracorporeal blood purification: an in vitro study. Blood Purif. 2020;49(1\u20132):33\u201343.","journal-title":"Blood Purif"},{"issue":"4","key":"4310_CR93","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10047-022-01323-6","volume":"25","author":"T Kishikawa","year":"2022","unstructured":"Kishikawa T, Fujieda H, Sakaguchi H. Comprehensive analysis of cytokine adsorption properties of polymethyl methacrylate (PMMA) membrane material. J Artif Organs. 2022;25(4):343\u20139.","journal-title":"J Artif Organs"},{"issue":"3","key":"4310_CR94","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10047-020-01173-0","volume":"23","author":"K Moriyama","year":"2020","unstructured":"Moriyama K, Kato Y, Hasegawa D, Kurimoto Y, Kawaji T, Nakamura T, Kuriyama N, Shimomura Y, Nishida O. Involvement of ionic interactions in cytokine adsorption of polyethyleneimine-coated polyacrylonitrile and polymethyl methacrylate membranes in vitro. J Artif Organs. 2020;23(3):240\u20136.","journal-title":"J Artif Organs"},{"issue":"4","key":"4310_CR95","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1744-9987.2011.00971.x","volume":"15","author":"M Yumoto","year":"2011","unstructured":"Yumoto M, Nishida O, Moriyama K, Shimomura Y, Nakamura T, Kuriyama N, Hara Y, Yamada S. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration. Ther Apher Dial. 2011;15(4):385\u201393.","journal-title":"Ther Apher Dial"},{"issue":"1","key":"4310_CR96","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ams2.382","volume":"6","author":"S Kobashi","year":"2019","unstructured":"Kobashi S, Maruhashi T, Nakamura T, Hatabayashi E, Kon A. The 28-day survival rates of two cytokine-adsorbing hemofilters for continuous renal replacement therapy: a single-center retrospective comparative study. Acute Med Surg. 2019;6(1):60\u20137.","journal-title":"Acute Med Surg"},{"issue":"2","key":"4310_CR97","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10047-018-1025-6","volume":"21","author":"H Mukaida","year":"2018","unstructured":"Mukaida H, Matsushita S, Inotani T, Nakamura A, Amano A. Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass. J Artif Organs. 2018;21(2):188\u201395.","journal-title":"J Artif Organs"},{"issue":"1","key":"4310_CR98","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13613-020-0648-y","volume":"10","author":"A Karkar","year":"2020","unstructured":"Karkar A, Ronco C. Prescription of CRRT: a pathway to optimize therapy. Ann Intensive Care. 2020;10(1):32.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"4310_CR99","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s13054-020-03322-6","volume":"24","author":"G Villa","year":"2020","unstructured":"Villa G, Romagnoli S, De Rosa S, Greco M, Resta M, Pomare Montin D, Prato F, Patera F, Ferrari F, Rotondo G, et al. Blood purification therapy with a hemodiafilter featuring enhanced adsorptive properties for cytokine removal in patients presenting COVID-19: a pilot study. Crit Care. 2020;24(1):605.","journal-title":"Crit Care"},{"issue":"8","key":"4310_CR100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220444","volume":"14","author":"ME Broman","year":"2019","unstructured":"Broman ME, Hansson F, Vincent JL, Bodelsson M. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: a randomized crossover double-blind study. PLoS ONE. 2019;14(8): e0220444.","journal-title":"PLoS ONE"},{"issue":"2","key":"4310_CR101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ccc.2021.11.013","volume":"38","author":"JA Kellum","year":"2022","unstructured":"Kellum JA, Formeck CL, Kernan KF, Gomez H, Carcillo JA. Subtypes and mimics of sepsis. Crit Care Clin. 2022;38(2):195\u2013211.","journal-title":"Crit Care Clin"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04310-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04310-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04310-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T19:27:23Z","timestamp":1728847643000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04310-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4310"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04310-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Claudio Ronco acts as an advisory board member for ASAHI, Baxter, GE, Jafron, and Medtronic and has received speaker fees from Astute, bioM\u00e9rieux, B. Braun, CytoSorbents, ESTOR, FMC, and Toray, all unrelated to the submitted work. John A. Kellum discloses inventorship on a patent application held by the Universities of Pittsburgh, and Munster, and Astute Medical (US2018\/074054A1) for use of TIMP-2 and IGFBP7 in conjunction with interventions to protect the kidney. Lakhmir Chawla reports consulting fees from BioPorto Medical and Exthera Medical. Lakhmir Chawla is a board member and stockholder of Exthera Medical, Stavro Medical, and Proletariat Therapeutics. Faeq Husain-Syed declares that there are no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}